A型血友病的美國市場:NPS+

本報告提供美國的A型血友病市場相關調查分析，提供促進部分A型血友病治療藥高忠誠度(權利金)和滿意度的理由，及醫生的選擇的要素，領導品牌的比較等的知識和見識。

報告的內容

• 各品牌NPS得分比較
• 醫師對特定品牌的忠誠度如何？
• 哪些品牌訊息能引起醫師的共鳴？
• 哪些因素會影響醫師的選擇？
• 主要品牌的市佔率
• 主要品牌與競爭對手的比較
• 由於品牌滿意度低，可能更換的品牌

領導品牌

There are various options available to US haematologists treating haemophilia A. Clearly some of these options are achieving greater levels of loyalty and satisfaction than others - but why? What are the key factors driving physician choice and how does each of the leading brands compare to its competitors? Gain insights into various haemophilia A therapies in the US.

Key Questions Answered:

• 1. How do NPS scores by brand compare?
• 2. How loyal are physicians to specific brands?
• 3. What brand messages resonate with physicians?
• 4. What are the key factors driving physician choice?
• 5. What is the market share of leading brands?
• 6. How does each of the leading brands compare to its competitors?
• 7. Which brands are vulnerable to switching due to low brand satisfaction?

Key Brands:

Methodology:

FirstView reports are developed from quantitative surveys conducted with physicians selected through LiMATM, the world's largest physician directory, containing over 3 million vetted and verified physicians. Each physician is carefully chosen based on strict screening criteria to ensure the insights gathered are both relevant and reliable, reflecting the true sentiments and experiences of leading medical professionals. The findings are presented in a series of easy-to-interpret charts, enabling you to quickly grasp and analyze the data. By leveraging the vast reach and precision of LiMATM, FirstView Reports provide unparalleled, data-driven insights to guide your strategic planning and help you stay ahead in a fast-evolving healthcare landscape.

What makes our reports different?

FirstWord Reports, a trusted industry leader with an exclusive focus on the pharmaceutical sector, delivers in-depth, actionable insights for biopharma professionals and decision-makers. Our deep industry knowledge enables us to provide relevant and valuable insights that help you identify emerging trends and navigate complex challenges effectively. Backed by extensive research and independent, impartial insights from leading experts and KOLs, our reports deliver the accuracy and reliability you need. With exclusive access to interviews and data unavailable elsewhere, along with ongoing market monitoring, we give you a comprehensive view of market dynamics. Covering over 40 dynamic disease areas and providing physician intelligence, including KOL insights and quantitative physician surveys, as well as industry expert views on issues in medical affairs, digital health, sales & marketing, market access, and other areas, our reports empower you to make smarter, data-driven decisions and maintain a competitive edge in a fast-moving industry.